77 related articles for article (PubMed ID: 22594272)
1. In vitro activity of the azole compounds against clinical fungal strains.
Ciok-Pater E; Gospodarek E; Modzelewska-Banachiewicz B; Ucherek M; Prazyńska M
Acta Pol Pharm; 2012; 69(3):565-7. PubMed ID: 22594272
[No Abstract] [Full Text] [Related]
2. Synthesis and evaluation of novel azoles as potent antifungal agents.
Li L; Ding H; Wang B; Yu S; Zou Y; Chai X; Wu Q
Bioorg Med Chem Lett; 2014 Jan; 24(1):192-4. PubMed ID: 24332489
[TBL] [Abstract][Full Text] [Related]
3. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
Sheng C; Zhang W; Ji H; Zhang M; Song Y; Xu H; Zhu J; Miao Z; Jiang Q; Yao J; Zhou Y; Zhu J; Lü J
J Med Chem; 2006 Apr; 49(8):2512-25. PubMed ID: 16610794
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of non-Aspergillus allergenic fungal species to azoles.
Duddy NE; Moore CB; Howard SJ; Denning DW
J Antimicrob Chemother; 2009 Apr; 63(4):834-6. PubMed ID: 19221103
[No Abstract] [Full Text] [Related]
5. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents.
Fang B; Zhou CH; Rao XC
Eur J Med Chem; 2010 Sep; 45(9):4388-98. PubMed ID: 20598399
[TBL] [Abstract][Full Text] [Related]
7. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.
Emami S; Foroumadi A; Falahati M; Lotfali E; Rajabalian S; Ebrahimi SA; Farahyar S; Shafiee A
Bioorg Med Chem Lett; 2008 Jan; 18(1):141-6. PubMed ID: 18032039
[TBL] [Abstract][Full Text] [Related]
8. [Criteria for sensitivity to azoles].
Gil Tomás J; Rubio Calvo C; Benito Ruesca R
Rev Esp Quimioter; 2004 Mar; 17(1):83-90. PubMed ID: 15201929
[No Abstract] [Full Text] [Related]
9. New azoles with antifungal activity: Design, synthesis, and molecular docking.
Chai X; Zhang J; Cao Y; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
Bioorg Med Chem Lett; 2011 Jan; 21(2):686-9. PubMed ID: 21190856
[TBL] [Abstract][Full Text] [Related]
10. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Pesti M; Papp T; Vágvölgyi C
FEMS Microbiol Lett; 2010 Jun; 307(2):175-84. PubMed ID: 20636975
[TBL] [Abstract][Full Text] [Related]
11. Antimycotic effects of some antibiotics on the growth of some dermatophytes and other keratin degrading fungi.
Singh CJ; Singh BG
Hindustan Antibiot Bull; 1997; 39(1-4):61-3. PubMed ID: 10386017
[TBL] [Abstract][Full Text] [Related]
12. [In vitro resistance of Candida species to antifungal agents].
Banach-Piatkowska W; Kotłowski A; Humanowska J; Mayer L; Kowalczyk D
Wiad Parazytol; 2001; 47(4):811-6. PubMed ID: 16886432
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of antifungal benzoheterocyclic derivatives by scaffold hopping.
Sheng C; Che X; Wang W; Wang S; Cao Y; Yao J; Miao Z; Zhang W
Eur J Med Chem; 2011 May; 46(5):1706-12. PubMed ID: 21411192
[TBL] [Abstract][Full Text] [Related]
14. [Biochemistry of azole derivatives and the problem of drug resistance].
Kerridge D; Parker S
Ann Dermatol Venereol; 1989; 116 Suppl 1():7-9. PubMed ID: 2688527
[No Abstract] [Full Text] [Related]
15. Modern aspects of testing azole antifungals.
Haller I
Postgrad Med J; 1979 Sep; 55(647):681-2. PubMed ID: 392484
[TBL] [Abstract][Full Text] [Related]
16. Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-[2-[4-aryl-piperazin-1-yl]-ethyl]-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol.
Upadhayaya RS; Sinha N; Jain S; Kishore N; Chandra R; Arora SK
Bioorg Med Chem; 2004 May; 12(9):2225-38. PubMed ID: 15080922
[TBL] [Abstract][Full Text] [Related]
17. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
Yamazaki T; Inagaki Y; Fujii T; Ohwada J; Tsukazaki M; Umeda I; Kobayashi K; Shimma N; Page MG; Arisawa M
Int J Antimicrob Agents; 2010 Oct; 36(4):324-31. PubMed ID: 20674282
[TBL] [Abstract][Full Text] [Related]
19. Serum or bile affects the in vitro azole susceptibilities of Candida spp.
Nagi M; Tanabe K; Takano Y; Kikuchi K; Miyazaki Y; Niimi M
Jpn J Infect Dis; 2009 Jul; 62(4):306-8. PubMed ID: 19628912
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and activities of naphthalimide azoles as a new type of antibacterial and antifungal agents.
Zhang YY; Zhou CH
Bioorg Med Chem Lett; 2011 Jul; 21(14):4349-52. PubMed ID: 21669530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
